tivozanib

Aveo Screwed Up but Its Kidney Cancer Drug Is Real

Aveo Screwed Up but Its Kidney Cancer Drug Is Real

TheStreet.com

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players

Motley Fool

Bristol-Myers Has The Future Of Oncology Therapies

Bristol-Myers Has The Future Of Oncology Therapies

Seeking Alpha

AVEO: Here's Looking At You, FDA

AVEO: Here's Looking At You, FDA

Seeking Alpha

Aveo Gets Bad News On Tivozanib

Aveo Gets Bad News On Tivozanib

Seeking Alpha

Aveo, Delcath FDA Panel Live Blog

Aveo, Delcath FDA Panel Live Blog

TheStreet.com

Aveo Kidney Cancer Drug May Need More Study, FDA Says

Aveo Kidney Cancer Drug May Need More Study, FDA Says

Bloomberg

Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel

Why Aveo's Kidney Cancer Drug Will Be Turned Down By Next Week's FDA Panel

TheStreet.com

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Aveo's Inflection Point: Tivozanib Likely To Receive Positive Advisory Vote, FDA Approval

Seeking Alpha

Why We Expect The FDA To Approve Aveo's Tivozanib

Why We Expect The FDA To Approve Aveo's Tivozanib

Seeking Alpha